Clinical Trials on Neoadjuvant Chemoimmunotherapy in Norway

Total 1 results

  • Gustave Roussy, Cancer Campus, Grand Paris
    Recruiting
    High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (HR-NBL2)
    High-Risk Neuroblastoma | Patient With Insufficient Response Chemoimmunotherapy
    France, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe